Toxic Cycle of Adulterated Medicines - Cough Syrups Claiming Lives

A medicine has turned into poison for innocent lives. What is the real conspiracy behind the 'cough syrups' that have damaged the kidneys of vulnerable children and caused a spate of deaths in Madhya Pradesh and Rajasthan? Is the recurrent tragedy solely due to the profit motive of companies? A deep analysis of this toxic cycle of adulterated medicines, which is tarnishing the country's international reputation, systematic failures, and a direct question to the government.

Betrayed Trust - The Death Knell for Children in Madhya Pradesh

The recent series of tragedies in Madhya Pradesh and Rajasthan have shaken the nation. Preliminary investigations suggest that cough syrups consumed by the children were the cause b ehind the deaths of over 14 children due to kidney failure within a span of fifteen days. It is deeply tragic that children who took cough syrups like ‘Coldriff’ and ‘Nextro-DS’ in Chhindwara and other regions suffered severe illness, urinary cessation, and subsequently lost their lives.

Officials identified the syrups as being manufactured by the Shrisan Pharma unit based in Kancheepuram, Tamil Nadu. The facts uncovered during inspections at the company are heartbreaking. The syrups were found to contain the highly dangerous poisonous chemical 'Diethylene Glycol' (DEG) at a concentration of over 48.6 percent, far exceeding the permitted limit (0.1 percent). Reports clearly indicate that this poisonous chemical caused kidney failure in the children. This i ncident glaringly exposes how a profit-driven poison consumed the lives of innocent children.

No Lesson Learned from the Gambia Tragedy? Who Must We Question?

This incident once again raises serious questions about our drug regulatory system and corporate ethics. This is because such a disaster is not happening for the first time. In 2022, over 66 children in the African nation of Gambia died after consuming Indian cough syrups contaminated with the same 'Diethylene Glycol' (DEG). The World Health Organization (WHO) issued a warning that the syrups exported by a Haryana-based pharma company also contained this toxic chemical.

The incident in Madhya Pradesh proves that even after the tragedy in Gambia tarnished India's reputation on the international stage, the situation in our country has barely changed. Two years ago, it was one company, now it's another... the contamination remains the same, and the victims are still innocent children. So, what happened to the stringent measures taken by the central and state governments during these two years? Why have they failed to tighten quality inspections? Whose failure is it that an international warning could not be translated into protection for the poor masses in our own country?

Is Profit Paramount? Is Life Meaningless? The Secret Behind Adulteration

Th e truth is that safer solvents like 'Propylene Glycol' or 'Glycerin' should be used in the manufacturing of cough syrups. These help to improve the taste and increase the stability of the medicine. However, these safer chemicals are expensive. Instead, some unscrupulous manufacturers use cheap industrial chemicals like 'Diethylene Glycol' (DEG) or 'Ethylene Glycol' (EG) as solvents simply to gain higher profits.

DEG and EG are cheap but highly poisonous. They are primarily used in the automotive industry as anti-freezes. When used in medicines, they severely affect the kidneys, liver, and brain, leading to immediate death. Do the company owners not know how dangerous it is to use these toxic chemicals and how much cost they could save? They know. This is where the conflict between ethics and business profits begins.

In the eyes of a certain industrialist, the marginal profit gained from a cheap chemical appears greater than the value of a human life. The lack of stringent laws, the low probability of punishment, and loopholes in the administrative machinery are the reasons for the owners' negligence. They view their workers and consumers merely as production t argets and profit figures, not as individuals with families, dreams, and valuable lives. This is a moral failure. Even though our laws are strict, the flaws in enforcement are giving courage to this adulteration mafia.

What Should the Government Do? Is Action on One Officer Enough?

In the c urrent situation, the government's response has drawn severe criticism. Immediate actions like suspending the Drug Controller in Rajasthan and conducting inspections have been taken. However, the question that needs deeper thought is whether taking action against just one officer will resolve this systematic failure.

The problem is not one person, it is in the entire system. Removing one officer will not stop the process of adulteration running in thousands of pharmaceutical companies. An officer's negligence is part of the system, but he is not the root cause of the entire problem. The critical question is whether every officer, from the lower level to the top, performed their duties properly.

The government's constructive response must begin with Strict Quality Control (Mandatory GMP). All pharmaceutical companies, particularly small and medium-sized units, must be compelled to adhere strictly to Good Manufacturing Practices (GMP) standards. These standards must be enforced in reality, not just as tick-box exercises on paper. Inspection teams should conduct sudden raids, and regulatory bodies must be empowered to impose devastatingly heavy fines or permanently revoke the manufacturing license if GMP guidelines are not followed. Furthermore, there must be Enhanced Testing and Source Identification. Every raw material utilized in drug production, especially solvents like Propylene Glycol and Glycerin, must be mandatorily subjected to rigorous testing for Diethylene Glycol (DEG) at the manufacturing company level. The supply chain is where this poison often enters, meaning th e sources of the small and medium-sized companies supplying this chemical—must also be identified, with strict legal action taken against them to cut off the contamination at its roots. To ensure national security against toxic drugs, better Central-State Cooperation and a National Alert System is critical. There must be seamless coordination between the Central Drug Standard Control Organisation (CDSCO) and all state regulatory bodies. A robust National Alert System must be established to ensure that any medicine banned or recalled in one state is immediately withdrawn across the entire country or from all supplied regions. This is the only way to ensure rapid information dissemination and prevent further deaths. Alongside systemic changes, Transparency and Accountability must be non-negotiable. Inspection reports and quality test results of pharma companies should be made public. Crucially, when adulteration occurs, penalties must move far beyond mere fines. Homicide or attempt-to-homicide charges should be filed against the company owners and prosecuted severely, with these cases being resolved in fast-track courts to ensure swift convictions. Only such drastic measures will instill the necessary fear and ethical discipline in the owners. Finally, there needs to be better Risk Warning and Public Participation. Doctors and pharmacy staff must receive continuous, mandatory training on the dangers posed by toxic medicines. The central government's warning that cough syrups should not be given to children under 2 years without a doctor's prescription must be strictly enforced. Concurrently, the public needs empowerment through education on how to check the quality and batch number of the medicines they purchase, making them the final line of defense.

Who Are the Regulations For?

These tragedies of adulterated medicines reveal not only systemic failures but also a lack of social justice. The children who are dying are mostly from poor and middle-class families. Those with money and power can immediately opt for better treatment or imported medicines. But these helpless families are falling victim to counterfeit drugs.

It is a grave crime for pharmaceutical companies to attempt to maximize profits by putting lives at risk, without minimum responsibility towards public health. India, which boasts of being the "Pharmacy Hub of the World," must first provide safe medicines to its own citizens. Otherwise, we will be responsible for bringing upon ourselves the ill repute of being a country that manufactures "toxic medicines" internationally.

The death of every child is a question posed to the entire country's system. If we fail to change even after the Gambia incident, preventing such tragedies from recurring in the future will be impossible. The government must move beyond mere inspections and initiate a root-level cleanup of the pharmaceutical sector. The responsibility lies with the regulatory bodies, and especially the governments, to prove that the value of people's lives is greater than the profits of the adulterers. The negligence of rulers and the lethargy of officials must end, and the iron fist must come down upon the adulteration mafia.